Navigation und Service

Zielgruppeneinstiege

Ausgewählte Publikationen 2014

Weidemann F, Dehnert M, Koch J, Wichmann O, Höhle M (2014): Modelling the epidemiological impact of rotavirus vaccination in Germany – A Bayesian approach.
Vaccine 32 (40): 5250-5257. Epub Jul 18. doi: 10.1016/j.vaccine.2014.06.090.
mehr

Weidemann F, Dehnert M, Koch J, Wichmann O, Höhle M (2014): Bayesian parameter inference for dynamic infectious disease modelling: rotavirus in Germany.
Statist. Med. 33 (9): 1580–1599. Epub 2013 Nov 25. doi: 10.1002/sim.6041.
mehr

Takla A, Wichmann O, Rieck T, Matysiak-Klose D (2014): Measles incidence in Germany, 2007–2011. Review of surveillance and insurance data towards measles elimination in Germany.
Bull. World Health Org. 92 (10): 742-749. Epub Aug 15. doi: 10.2471/BLT.13.135145.
mehr

Takla A, Wichmann O, Koch J, Terhardt M, Hellenbrand W (2014): Survey of pediatricians in Germany reveals important challenges for possible implementation of meningococcal B vaccination.
Vaccine 32 (48): 6349–6355. Epub Oct 1. doi: 10.1016/j.vaccine.2014.09.040.
mehr

Takla A, Böhmer MM, Klinc C, Kurz N, Schaffer A, Stich H, Stöcker P, Wichmann O, Koch J (2014): Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011.
Hum. Vaccin. Immunother. 10 (1): 1-6. Epub 2013 Oct 3. doi: 10.4161/hv.26642.
mehr

Siedler A, Dettmann M (2014): Hospitalization with varicella and shingles before and after introduction of general childhood varicella vaccination in Germany.
Hum. Vaccin. Immunother. 10 (12): 3594–3600. Epub Nov 1. doi: 10.4161/hv.34426.
mehr

Riffelmann M, Mohr J, Hellenbrand W, Wirsing von König CH (2014): Time since last vaccine dose in PCR-positive and PCR-negative children with suspected pertussis to monitor pertussis vaccine effectiveness.
Eur. J. Clin. Microbiol. Infect. Dis. 33 (5): 805-808. Epub 2013 Dec 1. doi: 10.1007/s10096-013-2016-4.
mehr

Rieck T, Feig M, Eckmanns T, Benzler J, Siedler A, Wichmann O (2014): Vaccination coverage among children in Germany estimated by analysis of health insurance claims data.
Hum. Vaccin. Immunother. 10 (2): 476-484. Epub 2013 Nov 5. doi: 10.4161/hv.26986.
mehr

Rieck T, Feig M, Deleré Y, Wichmann O (2014): Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany.
Vaccine 32 (43): 5564–5569. Epub Aug 12. doi: 10.1016/j.vaccine.2014.07.105.
mehr

Remschmidt C, Wichmann O, Harder T (2014): Influenza vaccination in patients with end-stage renal disease: Systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety.
BMC Med. 12 (1): 244. Epub Dec 19. doi: 10.1186/s12916-014-0244-9.
mehr

Remschmidt C, Wichmann O, Harder T (2014): Methodological quality of systematic reviews on influenza vaccination.
Vaccine 32 (15): 1678-1684. Epub Feb 7. doi: 10.1016/j.vaccine.2014.01.060.
mehr

Remschmidt C, Walter D, Schmich P, Wetzstein M, Deleré Y, Wichmann O (2014): Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site.
Hum. Vaccin.Immunother. 10 (9): 2527-2535. Epub Oct 30. doi: 10.4161/21645515.2014.970920.
mehr

Remschmidt C, Fesenfeld M, Kaufmann AM, Delere Y (2014): Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies.
BMC Public Health 14: 1248. Epub Dec 5. doi: 10.1186/1471-2458-14-1248.
mehr

Petersen S, Rabenau HF, Mankertz A, Matysiak-Klose D et al. (2014): Immunität gegen Masern beim medizinischen Personal des Universitätsklinikums Frankfurt, 2003–2013.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: Epub Dec 5. doi: 10.1007/s00103-014-2098-x.
mehr

Mereckiene J, Cotter S, Nicoll A et al.; the VENICE project gatekeepers group (for Germany Reiter S, Wichmann O) (2014): Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11).
Euro Surveill. 19 (16): pii=20780.
mehr

Lassen SG, Schuster M, Stemmler M, Steinmüller A, Matysiak-Klose D, Mankertz A, Santibanez S, Wichmann O, Falkenhorst G (2014): Measles outbreak spreading from the community to an anthroposophic school, Berlin, 2011.
Epidemiol. Infect. 142 (04): 789-796. Epub 2013 Jul 3. doi: 10.1017/S0950268813001398.
mehr

Harder T, Takla A, Rehfuess E, Sánchez-Vivar A, Matysiak-Klose D, Eckmanns T, Krause G, de Carvalho Gomes H, Jansen A, Ellis S, Forland F, James R, Meerpohl JJ, Morgan A, Schünemann H, Zuiderent-Jerak T, Wichmann O (2014): Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools.
BMC Med. Res. Methodol. 14 (1): 69. Epub May 21. doi: 10.1186/1471-2288-14-69.
mehr

Harder T (2014): Some notes on critical appraisal of prevalence studies: Comment on: "The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence".
Int. J. Health Policy Manag. 3 (5): 289–290. Epub Oct 11. doi: 10.15171/ijhpm.2014.99.
mehr

Galanakis E, D’Ancona F, Jansen A, Lopalco PL; VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points4 (for Germany Wichmann O) (2014): The issue of mandatory vaccination for healthcare workers in Europe.
Expert Rev. Vaccines 13 (2): 277–283. Epub 2013 Dec 18. doi: 10.1586/14760584.2014.869174.
mehr

Frank C, Faber M, Hellenbrand W, Wilking H, Stark K (2014): Wichtige, durch Vektoren übertragene Infektionskrankheiten beim Menschen in Deutschland. Epidemiologische Aspekte.
Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 57 (5): 557–567. doi: 10.1007/s00103-013-1925-9.
mehr

Falkenhorst G, Harder T, Remschmidt C et al. (2014): Erratum to: Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2–6 years in Germany.
Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 57 (4): 473–474. Epub Mar 22. doi: 10.1007/s00103-014-1938-z.
mehr

Deleré Y, Remschmidt C, Leuschner J, Schuster M, Fesenfeld M, Schneider A, Wichmann O, Kaufmann AM (2014): Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling.
BMC Infect. Dis. 14 (1): 87. Epub Feb 19. doi: 10.1186/1471-2334-14-87.
mehr

Bödeker B, Wichmann O et al. (2014): Umsetzung der Influenzaimpfempfehlung in Alten- und Pflegeheimen: Ergebnisse einer Erhebung im Rahmen der nationalen Influenza-Impfaufklärungskampagne.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57 (11): 1315-1321. Epub Sep 30. doi: 10.1007/s00103-014-2044-y.
mehr

Bödeker B, Walter D, Reiter S, Wichmann O (2014): Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany.
Vaccine 32 (33): 4131-4139. Epub Jun 10. doi: 10.1016/j.vaccine.2014.06.007.
mehr

Bödeker B, Remschmidt C, Müters S, Wichmann O (2014): Impfquoten unter Erwachsenen in Deutschland für die Impfungen gegen saisonale Influenza, Tetanus und Pertussis.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: Epub Dec 2. doi: 10.1007/s00103-014-2097-y.
mehr

Bayer C, Remschmidt C, an der Heiden M, Tolksdorf K, Herzhoff M, Kaersten S, Buda S, Haas W, Buchholz U (2014): Internet-based syndromic monitoring of acute respiratory illness in the general population of Germany, weeks 35/2011 to 34/2012.
Euro Surveill. 19 (4): pii=20684.
mehr

Aidelsburger P, Grabein K, Böhm K, Dietl M, Wasem J, Koch J, Ultsch B, Weidemann F, Wichmann O (2014): Cost-effectiveness of childhood rotavirus vaccination in Germany.
Vaccine 32 (17): 1964-1974. Epub Feb 20. doi: 10.1016/j.vaccine.2014.01.061.
mehr

Gesundheitsmonitoring

In­fek­ti­ons­schutz

Forschung

Kom­mis­sio­nen

Ser­vice

Das Robert Koch-Institut ist ein Bundesinstitut im Geschäftsbereich des Bundesministeriums für Gesundheit

© Robert Koch-Institut

Alle Rechte vorbehalten, soweit nicht ausdrücklich anders vermerkt.